Fig. 2From: Intended preoperative trans-arterial embolization for large hepatocellular carcinoma: a retrospective cohort studyPrognostic analyses for TAE and non-TAE groups. Patients treated with the intended preoperative TAE showed relatively better prognoses in the 2-year RFS (p=0.049) and 5-year DSS (p=0.200), compared to those without preoperative TAE. RFS, recurrence-free survival; DSS, disease-specific survival; TAE, trans-arterial embolizationBack to article page